Related Experiment Video
Updated: Jun 21, 2026

10:41
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
Published on: January 23, 2021
7.7K
Advances in cardiac tissue engineering and heart-on-a-chip
Jennifer Kieda1,2,3, Amid Shakeri1,2,3, Shira Landau1,2,3
1Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
Journal of Biomedical Materials Research. Part A
|November 1, 2023
Summary
Advancements in cardiac tissue engineering and heart-on-a-chip models rely on novel biomaterials and fabrication methods. These innovations aim to precisely control cardiac tissue properties for better disease modeling and therapeutic development.
Area of Science:
- Biomaterials Science
- Cardiovascular Research
- Tissue Engineering
Background:
- Cardiac tissue engineering and heart-on-a-chip technologies are rapidly advancing.
- These fields leverage new biomaterial development and innovative fabrication techniques.
- Precise control over mechanical, electrical, and structural properties of cardiac tissues is crucial for modeling mature phenotypes.
Purpose of the Study:
- To provide an overview of cardiac physiology and define requirements for functional tissue recapitulation.
- To discuss commonly used biomaterials in cardiac tissue engineering and heart-on-a-chip.
- To review recent representative studies and outline common challenges in both fields.
Main Methods:
- Review of cardiac physiology requirements.
- Discussion of biomaterials used in cardiac tissue engineering and heart-on-a-chip.
- Analysis of recent studies and identification of common challenges.
Main Results:
- Induced pluripotent stem cell-derived cardiac patches have advanced to human testing.
- Heart-on-a-chip platforms are widely adopted by pharmaceutical and biotechnology companies.
- Key challenges include scalable fabrication, platform standardization, vascularization, maturation, and cryopreservation.
Conclusions:
- Functional cardiac tissue recapitulation requires careful consideration of biomaterials and fabrication.
- Significant challenges remain in translating these technologies for widespread clinical and research use.
- Future efforts should focus on standardization, maturation, vascularization, and cryopreservation for 'off-the-shelf' availability.
Related Concept Videos
Heart Valves
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Development of the Heart
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

